Akari Therapeutics PLC
F:CLA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Akari Therapeutics PLC
F:CLA
|
US |
|
P
|
Planisware SA
VSE:PLNW
|
FR |
|
Delivra Health Brands Inc
F:3F0
|
CA |
|
S
|
Saul Centers Inc
F:SA4
|
US |
|
MilDef Group AB
F:8QA
|
SE |
|
P
|
PennyMac Financial Services Inc
F:1AC
|
US |
|
Shanghai Electric Group Co Ltd
SSE:601727
|
CN |
|
Venus Concept Inc
OTC:VERO
|
CA |
|
C
|
CNX Resources Corp
F:CGD
|
US |
|
Actelis Networks Inc
OTC:ASNS
|
US |
|
CleanGo Innovations Inc
F:APO
|
CA |
|
R
|
Rathbones Group PLC
OTC:RTBBF
|
UK |
|
F
|
Flowserve Corp
F:FWV
|
US |
|
E
|
Ems Chemie Holding AG
XMUN:EMC1
|
CH |
Bankruptcy Probability
Akari Therapeutics PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Akari Therapeutics PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Akari Therapeutics PLC
NASDAQ:AKTX
|
18.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
570.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
211.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
223.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
344.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Akari Therapeutics PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Akari Therapeutics PLC has total debt of 754k USD. This includes both short-term (754k USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
